Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie L Sherman

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Journal of Genetic Counseling|January 31, 2020
Health knowledge of women with a fragile X premutation: Improving understanding with targeted educational materialLiana Smolich, Krista Charen, Stephanie L Sherman
Science (New York, N.Y.)|February 13, 2010
Genetics. Genetic control of hotspotsVivian G Cheung, Stephanie L Sherman, Eleanor Feingold
Journal of Genetic Counseling|February 14, 2007
Attitudes toward fragile X mutation carrier testing from women identified in a general population surveyAimee Anido, Lisa M Carlson, Stephanie L Sherman
Prenatal Diagnosis|February 17, 2021
Analyses stratified by maternal age and recombination further characterize genes associated with maternal nondisjunction of chromosome 21Jonathan M Chernus, Stephanie L Sherman, Eleanor Feingold
Wiley Interdisciplinary Reviews. Cognitive Science|December 9, 2014
Cognitive aspects of Fragile X syndromeLillie B Huddleston, Jeannie Visootsak, Stephanie L Sherman
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 17, 2004
Maternal meiosis II nondisjunction in trisomy 21 is associated with maternal low socioeconomic statusRoberta E Christianson, Stephanie L Sherman, Claudine P Torfs
Annals of the New York Academy of Sciences|June 25, 2008
Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiencyJohn J De Caro, Celia Dominguez, Stephanie L Sherman
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 23, 2008
Clinical significance of tri-nucleotide repeats in Fragile X testing: a clarification of American College of Medical Genetics guidelinesKathryn E Kronquist, Stephanie L Sherman, Elaine B Spector
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 7, 2009
Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literatureJessica Ezzell Hunter, Ann Abramowitz, Michele Rusin, et al.
Journal of Genetic Counseling|July 28, 2005
Women's attitudes toward testing for fragile X carrier status: a qualitative analysisAimee Anido, Lisa M Carlson, Lisa Taft, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Journal of Genetic Counseling|January 31, 2020
Health knowledge of women with a fragile X premutation: Improving understanding with targeted educational materialLiana Smolich, Krista Charen, Stephanie L Sherman
Science (New York, N.Y.)|February 13, 2010
Genetics. Genetic control of hotspotsVivian G Cheung, Stephanie L Sherman, Eleanor Feingold
Journal of Genetic Counseling|February 14, 2007
Attitudes toward fragile X mutation carrier testing from women identified in a general population surveyAimee Anido, Lisa M Carlson, Stephanie L Sherman
Prenatal Diagnosis|February 17, 2021
Analyses stratified by maternal age and recombination further characterize genes associated with maternal nondisjunction of chromosome 21Jonathan M Chernus, Stephanie L Sherman, Eleanor Feingold
Wiley Interdisciplinary Reviews. Cognitive Science|December 9, 2014
Cognitive aspects of Fragile X syndromeLillie B Huddleston, Jeannie Visootsak, Stephanie L Sherman
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 17, 2004
Maternal meiosis II nondisjunction in trisomy 21 is associated with maternal low socioeconomic statusRoberta E Christianson, Stephanie L Sherman, Claudine P Torfs
Annals of the New York Academy of Sciences|June 25, 2008
Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiencyJohn J De Caro, Celia Dominguez, Stephanie L Sherman
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 23, 2008
Clinical significance of tri-nucleotide repeats in Fragile X testing: a clarification of American College of Medical Genetics guidelinesKathryn E Kronquist, Stephanie L Sherman, Elaine B Spector
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 7, 2009
Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literatureJessica Ezzell Hunter, Ann Abramowitz, Michele Rusin, et al.
Journal of Genetic Counseling|July 28, 2005
Women's attitudes toward testing for fragile X carrier status: a qualitative analysisAimee Anido, Lisa M Carlson, Lisa Taft, et al.
Pageof 13